Copyright
©The Author(s) 2015.
World J Gastroenterol. Feb 14, 2015; 21(6): 1907-1914
Published online Feb 14, 2015. doi: 10.3748/wjg.v21.i6.1907
Published online Feb 14, 2015. doi: 10.3748/wjg.v21.i6.1907
Figure 4 Temporal formation of antibodies to infliximab in nine patients in whom antibodies to infliximab positive sera preceded double negative sera.
ATI formation before DN event (triangles), ATI formation after DN event (circles). ATI: Antibodies to infliximab; DN: Double negative.
- Citation: Ungar B, Anafy A, Yanai H, Ron Y, Yavzori M, Picard O, Fudim E, Loebstein R, Kopylov U, Chowers Y, Dotan I, Eliakim R, Ben-Horin S. Significance of low level infliximab in the absence of anti-infliximab antibodies. World J Gastroenterol 2015; 21(6): 1907-1914
- URL: https://www.wjgnet.com/1007-9327/full/v21/i6/1907.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i6.1907